01
Why people text us when they are sick
Innate-immunity science is compelling when you have a virus. Compelling is not compoundable.
- ·Not an antibiotic substitute
- ·Not orderable
- ·See actual medical care for infection
RE GEN RX · peptides / LL-37
No lawful pathway
LL-37
A host-defense peptide asked about in illness — no lawful §503A pathway.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · When clinically timed
What is LL-37?
The molecule, in plain language.
LL-37 is a cathelicidin antimicrobial peptide involved in innate immunity. Illness-only marketing is still marketing. RE GEN cannot lawfully compound it and will not offer it “when you are sick.”
How people usually take it. Not orderable — during illness or otherwise.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
TA-1 is also no
Thymosin Alpha-1 is a different immune modulator and also has no pathway here.
- ·TA-1 page
- ·Neither is a flu peptide we can send
- ·Do not stack research immune vials
03
What we will do
Tell you no, and help you start a visit for carried wellness tools after you are appropriately evaluated.
- ·No gray-market LL-37
- ·No “just this once”
- ·Honesty is the immune protocol
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
LL-37 has substantial innate-immunity preclinical literature.
- ·Not 503A eligibility
- ·Not orderable
- ·Not an infection treatment we sell
Human research
Human research exists; it does not open compounding at RE GEN. This page is not infectious-disease care.
- ·Not orderable
- ·Seek appropriate care for infection
- ·Do not delay antibiotics for a research peptide
Legal basis at RE GEN · July 2026
We will not compound this today.
No lawful §503A pathway at this time. We will not compound LL-37.
We will not compound this. Ask us what is carried instead.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is LL-37?
A cathelicidin host-defense peptide. Not orderable at RE GEN, including during illness.
Is LL-37 FDA-approved?
LL-37 is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get LL-37 at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound LL-37 today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
I’m sick — can you overnight it?
No. We cannot compound it. Get appropriate medical care for infection.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
We will tell you no — and show you what is carried instead.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.